Medical News

RSS

Drug to reverse immunological decline in aging

UCSF researchers have identified an existing medication that restores key elements of the immune system that, when out of balance, lead to a steady decline in immunity and health as people age.

14 Dec 2010

Top-line results from Inhibitex's FV-100 Phase II clinical trial for treatment of shingles

Inhibitex, Inc. today reported top-line safety and efficacy data from its Phase II clinical trial of FV-100, an oral antiviral compound being developed to treat herpes zoster, more commonly referred to as shingles. The study was the first clinical trial to assess the antiviral activity of FV-100, included 350 shingles patients and compared two once-daily doses of FV-100 (200 mg and 400 mg) to an active control, valacyclovir, one of the most commonly-used antiviral drugs to treat shingles.

14 Dec 2010

Novel labeling technique helps researchers to explore DNA chemical modification

Researchers at Emory University School of Medicine and the University of Chicago have developed a method for labeling and mapping a "sixth nucleotide," whose biological role scientists are only beginning to explore.

14 Dec 2010

Underwriters partially exercise over-allotment option in Cadence public offering

Cadence Pharmaceuticals, Inc. today announced that its underwriters partially exercised their over-allotment option in connection with its previously announced public offering that priced on November 11, 2010, by purchasing an additional 1,000,000 shares of its common stock at a public offering price of $8.00 per share. Including the over-allotment shares purchased, Cadence sold a total of 12,500,000 shares in the offering, resulting in expected aggregate gross proceeds to the company of $100 million.

14 Dec 2010

ACCESS receives $6.7M NIH Clinical and Translational Science Award

Access Community Health Network (ACCESS) has received a $6.7 million Clinical and Translational Science Award grant from the National Institutes of Health (NIH) to construct a community-based research center. The goal of the center's research will be to engage the community and reduce racial and ethnic disparities in health care.

14 Dec 2010

Hospital de Clinicas de Niteroi to acquire Samaritano

Amilpar, the largest healthcare company in Brazil, in accordance with CVM Instruction 358, of January 3, 2002, informs that the Hospital de Clinicas de Niteroi Ltda. ("HCN"), a company owned by our indirect controlling shareholder, has signed an Agreement to acquire up to 100% of the shares representatives of the capital stock of Hospital Samaritano ("Samaritano") for the total amount of R$ 180 million.

14 Dec 2010

Capstone presents AZX100 Phase 2a trial results for keloid and trocar site scarring

Capstone Therapeutics announced today twelve-month results from its two AZX100 Phase 2a pilot clinical trials in keloid scarring and seven-month interim results of its ongoing AZX100 Phase 2a pilot clinical trial in surgical (trocar site) scarring.

14 Dec 2010

BUSM professor wins 2010 Van Slyke Award for seminal contributions to laboratory medicine

Michael F. Holick, PhD, MD, a professor at Boston University School of Medicine (BUSM), is the recipient of the 2010 Van Slyke Award from the American Academy for Clinical Chemistry New York Metro Section.

14 Dec 2010

FOXA1 gene controls oestrogen-fuelled growth of breast cancer cells

CANCER RESEARCH UK scientists have discovered that a single gene controls the oestrogen-fuelled growth of breast cancer cells, according to research published in Nature Genetics on Sunday.

14 Dec 2010

EU, India talks end with resolution on drug seizures, little progress on free trade agreement

"The European Union and India resolved a dispute over generic drugs on Friday which should remove obstacles to Indian drugs manufacturers exporting products to the developing world, officials said," Reuters reports in an article that describes the customs regulations previously in place that led "to numerous seizures of generic drugs shipments in transit from India to countries in South America via Europe."

14 Dec 2010

FDA to review Lantheus' DEFINITY sNDA for use in stress echocardiography

Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's supplemental New Drug Application (sNDA) for DEFINITY® (Perflutren Lipid Microsphere) Injectable Suspension for use in stress echocardiography.

14 Dec 2010

New osteoporosis drug appears to reduce bone loss in mice with oral cancer

A drug currently approved for osteoporosis treatment has been shown to reduce bone loss in a study of mice with oral cancer, suggesting it could serve as an important supplemental therapy in patients with head and neck cancers that erode bone.

14 Dec 2010

Lilly suspends tasisulam global Phase III study in metastatic melanoma

Eli Lilly and Company announced today that it has suspended its global Phase III study evaluating tasisulam, an investigational, small-molecule anti-cancer compound, as a second-line treatment for those with unresectable or metastatic melanoma.

13 Dec 2010

State roundup: New Dem Gov. and Minn. Medicaid; Fla. docs on Medicaid changes; Iowa Gov. eyes long-term care loopholes; Conn. provider rates

Over the past decade, programs that integrate Medicaid and Medicare have resulted in improved consumer satisfaction, better health outcomes and lower Medicaid costs in Arizona, Massachusetts, Minnesota, New Mexico, New York, Wisconsin and Washington. In each case, states have had to change their Medicaid rules by attaining a waiver from the federal government (Vestal, 12/13).

13 Dec 2010

Majority of brain tumor patients use alternative therapies

Many people with incurable brain tumors use alternative therapies, such as taking vitamins and homeopathy, in addition to their conventional treatments, according to a study published in the December 14, 2010, print issue of Neurology®, the medical journal of the American Academy of Neurology.

13 Dec 2010

PREZISTA/ritonavir once-daily dosing for HIV-1 receives FDA approval for treatment in no DRV RAM adults

Tibotec Therapeutics, a division of Centocor Ortho Biotech Products, L.P., announced today that the U.S. Food and Drug Administration (FDA) has approved a revision to the dosing recommendation to include once-daily dosing of PREZISTA® (darunavir) tablets in combination with ritonavir for the treatment of human immunodeficiency virus (HIV-1) in treatment-experienced adult patients with no darunavir resistance-associated mutations (DRV RAMs).

13 Dec 2010

Research: Kidney disease caused by autoimmune disease lupus may be twice as lethal in children

Kidney disease caused by the autoimmune disease lupus may be twice as lethal in children as kidney disease caused by other disorders, according to research led by Johns Hopkins Children's Center investigators.

13 Dec 2010

Soda taxes – would they do any good?

According to new research from Duke-National University of Singapore (NUS) Graduate Medical School imposing higher taxes on sodas and other sweetened drinks would lead to only minimal weight loss among most people and would have no effect on weight among consumers in the highest and lowest income groups.

13 Dec 2010

Apartment living exposes kids to more second-hand smoke

A new study finds that kids who live in apartments have more tobacco contaminants in their blood than those who live in houses, even if smokers in the household refrain from smoking at home.

13 Dec 2010

Alzheimer’s research update

Alzheimer’s disease researchers have been working for a while with a small, sticky protein fragment, beta amyloid, that clumps into balls in the brains of patients with this degenerative neurological disease. It is a normal protein that is present in every normal brain but in Alzheimer’s it starts to accumulate into these balls or plaques. On buildup of amyloid symptoms of the disease appear.

13 Dec 2010

Medical News

Drug to reverse immunological decline in aging

Top-line results from Inhibitex's FV-100 Phase II clinical trial for treatment of shingles

Novel labeling technique helps researchers to explore DNA chemical modification

Underwriters partially exercise over-allotment option in Cadence public offering

ACCESS receives $6.7M NIH Clinical and Translational Science Award

Hospital de Clinicas de Niteroi to acquire Samaritano

Capstone presents AZX100 Phase 2a trial results for keloid and trocar site scarring

BUSM professor wins 2010 Van Slyke Award for seminal contributions to laboratory medicine

FOXA1 gene controls oestrogen-fuelled growth of breast cancer cells

EU, India talks end with resolution on drug seizures, little progress on free trade agreement

FDA to review Lantheus' DEFINITY sNDA for use in stress echocardiography

New osteoporosis drug appears to reduce bone loss in mice with oral cancer

Lilly suspends tasisulam global Phase III study in metastatic melanoma

State roundup: New Dem Gov. and Minn. Medicaid; Fla. docs on Medicaid changes; Iowa Gov. eyes long-term care loopholes; Conn. provider rates

Majority of brain tumor patients use alternative therapies

PREZISTA/ritonavir once-daily dosing for HIV-1 receives FDA approval for treatment in no DRV RAM adults

Research: Kidney disease caused by autoimmune disease lupus may be twice as lethal in children

Soda taxes – would they do any good?

Apartment living exposes kids to more second-hand smoke

Alzheimer’s research update

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News